NCT00202306View on ClinicalTrials.gov

Indicated Prevention of Psychotic Disorders With Low-dose Lithium

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
SchizophreniaBipolar DisorderPsychotic Disorders
Interventions
DRUG

lithium carbonate

Trial Locations (1)

3052

ORYGEN Youth Health, PACE Clinic, Parkville

Sponsors

Lead Sponsor

Melbourne Health
All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Melbourne Health

OTHER